Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOCSINS: Snake Venom Metalloproteinase Inhibitors for Snakebite Envenoming
NCT07500233Phase 2Not yet recruiting
- Sponsor
- Liverpool School of Tropical Medicine
- Start
- Jan 2027
- Primary completion
- Oct 2028
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of 2,3-Dimercapto-1-propanesulfonic acid, marimastat in snakebite envenoming, sponsored by Liverpool School of Tropical Medicine. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
2,3-Dimercapto-1-propanesulfonic acidmarimastat
03
Conditions
snakebite envenoming
Beyond the preview
Go deeper on NCT07500233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07500233.